The Brighterside of News on MSN
GLP-1 drugs like Ozempic and Wegovy are changing the foods Americans buy
The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial introduction to Americans, is showing many effects beyond just improving personal ...
The food and beverage giant is shining a light on a blossoming consumer trend that is impacting sales. PepsiCo (PEP) , which owns popular food and drink brands such as Pepsi, Lay’s, Gatorade, Tostitos ...
While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 medications like Ozempic and Wegovy may be changing something broader: the consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback